Care difficulties and burden during COVID-19 pandemic lockdowns among caregivers of people with schizophrenia: A cross-sectional study.
COVID-19
caregiver
lockdown
schizophrenia
Journal
Neuropsychopharmacology reports
ISSN: 2574-173X
Titre abrégé: Neuropsychopharmacol Rep
Pays: United States
ID NLM: 101719700
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
18
02
2021
received:
23
12
2020
accepted:
23
02
2021
pubmed:
26
3
2021
medline:
16
6
2021
entrez:
25
3
2021
Statut:
ppublish
Résumé
The purpose of this study was to retrospectively investigate care difficulties experienced by caregivers of people with schizophrenia during COVID-19 pandemic lockdowns in Japan (April 7-May 25, 2020) and examine associations between these care difficulties during lockdowns and daily caregiver burden. Data were collected from 132 participants of the LINE Schizophrenia Family Association using an online survey. Caregivers were mostly concerned about who would care for people with schizophrenia if caregivers become infected with COVID-19. A significant association was found between higher daily caregiver burden and more difficult care experiences during COVID-19 pandemic lockdowns (B = 0.58, 95% confidence interval, 0.40-0.75, P < .01, adjusted R-squared = .34). Further studies and supports for caregivers of people with schizophrenia are needed.
Identifiants
pubmed: 33764671
doi: 10.1002/npr2.12171
pmc: PMC8249994
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
242-247Informations de copyright
© 2021 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Society of Neuropsychopharmacology.
Références
Psychol Med. 2021 Apr;51(6):1054-1056
pubmed: 32423496
Psychiatry Clin Neurosci. 2010 Aug;64(4):377-86
pubmed: 20546168
Indian J Psychiatry. 2014 Jul;56(3):221-7
pubmed: 25316932
JAMA. 2014 Mar 12;311(10):1052-60
pubmed: 24618967
Community Ment Health J. 1994 Oct;30(5):473-94
pubmed: 7851101
Neuropsychopharmacol Rep. 2021 Jun;41(2):242-247
pubmed: 33764671
Gen Psychiatr. 2020 Jun 24;33(4):e100215
pubmed: 32656497
Lancet Psychiatry. 2020 Oct;7(10):883-892
pubmed: 32707037
Lancet Psychiatry. 2020 Aug;7(8):e53
pubmed: 32711715
Schizophr Res. 2020 Aug;222:3-5
pubmed: 32473931
Nihon Ronen Igakkai Zasshi. 2003 Sep;40(5):497-503
pubmed: 14579721
Schizophr Bull. 2020 Jul 8;46(4):752-757
pubmed: 32343342